| Name | (2S)-2-(phenylmethoxycarbonylamino)-3-pyrazol-1-ylpropanoic acid |
|---|---|
| Synonyms |
(2S)-2-benzyloxycarbonylamino-3-pyrazol-1-ylpropionic acid
2(S)-benzyloxycarbonylamino-3-pyrazol-1-ylpropionic acid (S)-2-(benzyloxycarbonylamino)-3-(1H-pyrazol-1-yl)propanoic acid N-[(benzyloxy)carbonyl]-3-(pyrazol-1-yl)-L-alanine |
| Density | 1.31 |
|---|---|
| Molecular Formula | C14H15N3O4 |
| Molecular Weight | 289.28700 |
| Exact Mass | 289.10600 |
| PSA | 93.45000 |
| LogP | 1.65360 |
| HS Code | 2933199090 |
|---|
|
~43%
20945-53-3 |
| Literature: Bristol-Myers Squibb Company Patent: US2008/44379 A1, 2008 ; Location in patent: Page/Page column 63 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933199090 |
|---|---|
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |